Latest Regulatory Approvals News

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.

Gold Mountain Limited has agreed to sell its Papua New Guinea exploration licences for $2 million, redirecting funds to advance its promising Brazilian projects and strengthen working capital.

RPMGlobal has secured a crucial Foreign Investment Review Board approval for its proposed acquisition by Caterpillar, marking a significant step forward in the takeover process.

LTR Pharma has initiated dosing in its Phase II clinical trial for SPONTAN, a rapid-acting intranasal spray targeting erectile dysfunction, marking a key step toward FDA approval and commercial expansion.

1414 Degrees updates on the administration of its joint venture partner Vast Solar Aurora, exploring acquisition options while progressing key renewable projects. The company also advances its October 2025 placement with shareholder-approved options now moving towards ASX quotation.

Infini Resources has completed a significant Phase 2 drilling campaign at its Portland Creek Uranium Project, alongside a strategic landholding expansion exceeding 120%, while confirming high-grade uranium at other Canadian projects.

Amplitude Energy has reported record quarterly production and revenue for Q2 FY26, alongside a dramatic reduction in net debt and the commencement of drilling for its East Coast Supply Project.

Ballard Mining Limited has launched a A$50 million placement to fund extensive drilling and early works at its fully permitted Baldock gold project in Western Australia, aiming for a maiden ore reserve and a final investment decision in 2026.

Chilwa Minerals has finalised the last tranche of its $8 million private placement, bolstered by insider participation, and is advancing plans for a Nasdaq dual listing in the first half of 2026.

Imricor Medical Systems has secured Virginia Commonwealth University Health as the third US site for its VISABL-AFL clinical trial, advancing its FDA approval pathway for MRI-guided cardiac ablation technology.

Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.